ID

43829

Description

IRESSA™ (Gefitinib) in Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00632723

Lien

https://clinicaltrials.gov/show/NCT00632723

Mots-clés

  1. 05/05/2016 05/05/2016 -
  2. 18/06/2016 18/06/2016 -
  3. 20/09/2021 20/09/2021 -
Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT00632723

Eligibility Breast Cancer NCT00632723

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histological or cytological confirmation of breast cancer that is either
Description

diagnosis of breast cancer

Type de données

boolean

Alias
UMLS CUI [1]
C0019638
a primary tumor in a patient unfit for or who has declined surgery
Description

patient with primary tumor

Type de données

boolean

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C0677930
UMLS CUI [2]
C0749192
advanced (locally or metastatic) disease
Description

advanced disease

Type de données

boolean

Alias
UMLS CUI [1]
C0679246
acquired resistance to tamoxifen or er negative tumour
Description

resistance to tamoxifen or ER negative tumour

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332325
UMLS CUI [1,2]
C0039286
UMLS CUI [2]
C2584629
at least one measurable or assessable lesion
Description

measurable disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
who performance status 0 - 2
Description

who performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy of 12 weeks or more
Description

life expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than one previous chemotherapy regimens for advanced disease
Description

previous chemotherapy regimens

Type de données

boolean

Alias
UMLS CUI [1,1]
C0205156
UMLS CUI [1,2]
C0392920
prior anthracycline chemotherapy (> 250 mg/m2 adriamycin)
Description

prior anthracycline chemotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C0003234
radiotherapy completed within 14 days prior to day 1 of treatment
Description

radiotherapy completed

Type de données

boolean

Alias
UMLS CUI [1]
C1522449
incomplete healing from prior oncologic or other major surgery
Description

incomplete healing from prior surgery

Type de données

boolean

Alias
UMLS CUI [1]
C0543478
signs of neurological symptoms consistent with spinal cord compression
Description

neurological symptoms with spinal cord compression

Type de données

boolean

Alias
UMLS CUI [1,1]
C0235031
UMLS CUI [1,2]
C0037926
any evidence of clinically active interstitial lung disease (patients with chronic stable
Description

active interstitial lung disease

Type de données

boolean

Alias
UMLS CUI [1]
C0206062

Similar models

Eligibility Breast Cancer NCT00632723

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
diagnosis of breast cancer
Item
histological or cytological confirmation of breast cancer that is either
boolean
C0019638 (UMLS CUI [1])
patient with primary tumor
Item
a primary tumor in a patient unfit for or who has declined surgery
boolean
C0677930 (UMLS CUI [1,1])
C0677930 (UMLS CUI [1,2])
C0749192 (UMLS CUI [2])
advanced disease
Item
advanced (locally or metastatic) disease
boolean
C0679246 (UMLS CUI [1])
resistance to tamoxifen or ER negative tumour
Item
acquired resistance to tamoxifen or er negative tumour
boolean
C0332325 (UMLS CUI [1,1])
C0039286 (UMLS CUI [1,2])
C2584629 (UMLS CUI [2])
measurable disease
Item
at least one measurable or assessable lesion
boolean
C1513041 (UMLS CUI [1])
who performance status
Item
who performance status 0 - 2
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy of 12 weeks or more
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
previous chemotherapy regimens
Item
more than one previous chemotherapy regimens for advanced disease
boolean
C0205156 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
prior anthracycline chemotherapy
Item
prior anthracycline chemotherapy (> 250 mg/m2 adriamycin)
boolean
C0003234 (UMLS CUI [1])
radiotherapy completed
Item
radiotherapy completed within 14 days prior to day 1 of treatment
boolean
C1522449 (UMLS CUI [1])
incomplete healing from prior surgery
Item
incomplete healing from prior oncologic or other major surgery
boolean
C0543478 (UMLS CUI [1])
neurological symptoms with spinal cord compression
Item
signs of neurological symptoms consistent with spinal cord compression
boolean
C0235031 (UMLS CUI [1,1])
C0037926 (UMLS CUI [1,2])
active interstitial lung disease
Item
any evidence of clinically active interstitial lung disease (patients with chronic stable
boolean
C0206062 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial